RENGA PAKEEREE: Open Payments
NPI 1285671537 · CUYAHOGA FALLS, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$30,117 in 206 payments from 16 companies in 2025. Trend: 2023 $38,147 · 2024 $16,476 · 2025 $30,117
Speaker / faculty: $11,535Consulting: $11,020Food & beverage: $5,037Travel & lodging: $2,491Education: $34
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 45 | $14,007 |
| E.R. Squibb & Sons, L.L.C. | 41 | $7,312 |
| ABBVIE INC. | 12 | $6,061 |
| Teva Pharmaceuticals USA, Inc. | 19 | $521 |
| Neurocrine BioSciences, Inc. | 15 | $431 |
| Alkermes, Inc. | 18 | $376 |
| Otsuka America Pharmaceutical, Inc. | 17 | $345 |
| Vanda Pharmaceuticals Inc. | 17 | $274 |
| Janssen Pharmaceuticals, Inc | 4 | $184 |
| Axsome Therapeutics, Inc. | 7 | $175 |
Products named: CAPLYTA, VRAYLAR, AUSTEDO XR, COBENFY, INGREZZA, REXULTI, FANAPT, ARISTADA.
Industry payments across OH — which companies pay providers there.
